Return to Article Details
SURVIVAL STUDY AND SOME FACTORS AFFECTING IN FIRST-LINE GEFITINIB TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION
Download
Download PDF